CooperVision launches Biofinity XR toric contact lenses

Contact lens manufacturer, CooperVision, has announced the introduction of Biofinity XR toric contact lenses. It is said to be a much-anticipated addition to the company’s range of monthly silicone hydrogel contact lenses.

CooperVision is highlighting that the Biofinity XR brand “is the only silicone hydrogel contact lens range from a major manufacturer designed for patients with prescriptions beyond the traditional stock range.”

It first introduced the Biofinity XR sphere lenses in late 2013, offering patients with severe near- and far-sightedness a combination of high oxygen permeability and all-day comfort.

With Biofinity XR toric, the benefits are extended to people who have both high prescriptions and astigmatism, typically patients who have had challenges with contact lenses in the past, or may even have thought that contact lens wear was not an option for them.

CooperVision’s vice president of global marketing, Guy Whittaker, said: “Biofinity XR toric contact lenses bring the proven comfort, clarity and stable fit of the Biofinity brand to people who may otherwise not have the opportunity to experience the benefits of silicone hydrogel wear.”

He added: “With our commitment to developing and manufacturing these unique lenses, practitioners can fit a greater number of patients in silicone hydrogels, keeping pace with the widespread move to this healthier material.”

Like all Biofinity lenses, the new toric lenses feature Aquaform  Technology, which enables more oxygen to reach the eyes, helping to maintain clear, white eyes and healthier corneal physiology. The lens material is uniformly wettable, providing a soft and flexible lens.

BiofinityXR toric lenses are available in sphere powers from -6.00D to -10.00D (0.50D steps), -6.00D to +6.00D (0.25D steps) with cylinder powers from -2.75 to -5.75 (0.50 steps) and an axis of five degrees to 180 degrees in five-degree steps, and +8.50D to +10.00D with cylinder powers from -0.75 to -2.25 (0.50 steps).

For more information, visit the CooperVision website.